HLN
$10.17+0.30%
as of close, Oct 20, 2026
☾ AH $10.17 +0.30%
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)Stock · Healthcare
HLN — Haleon plc American Depositary Shares (Each representing two Ordinary Shares) price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDEEDEEDEEDDDD
6.06.57.07.58.08.59.09.510.010.511.0050.0M100.0M$10.17—20222023202420252026
2026-10-20
Price$10.17
MA20$9.63
MA50$9.54
Vol39.0M
Key stats#
Price data
- Price
- $10.17
- YTD price return
- +0.59%
- YTD total return
- +2.60%
- Next earnings
- Oct 29, 2026 · Before open
- Market cap
- 45.5B
- Enterprise value
- 54.2B
- Shares outstanding
- 4.5B
- 52W low
- $8.65
- 52W high
- $11.28
- From 52W high
- -9.84%
- From 52W low
- +17.57%
- 52W range
- 58%
- Beta
- 0.11
Volume
- Rel volume
- 0.94×
- 30D volume
- 20M
- 30D $ vol
- 186.2M
Fundamentals
- Sales (ttm)
- 14.6B
- Sales/share
- $3.25
- EPS (ttm)
- $0.49
- FCF (ttm)
- 3.1B
- FCF/share
- $0.68
- Book value/share
- $4.94
- Net margin
- 15.23%
- ROE
- 10.03%
- ROA
- 5.05%
- Debt / equity
- 0.47×
- Current ratio
- 0.92
Growth (CAGR, ttm) · 10Y
- Sales
- +1.44%+2.84%+2.79%n/a
- Net income
- +17.68%+17.14%+7.92%n/a
- FCF
- +16.47%+12.06%+14.96%n/a
- Shares
- -1.45%-1.03%-0.62%n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +21.75%+19.87%+8.95%n/a
- Sales/share
- +2.93%+3.91%+3.43%n/a
- FCF/share
- +18.18%+13.23%+15.68%n/a
- Book value/share
- +10.64%+5.04%-8.59%n/a
- Dividend/share
- +12.56%-36.83%-22.81%n/a
- Price
- +8.08%+7.35%+7.42%n/a
- Total return
- +10.24%+9.33%+9.14%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 20.8×
- P/OI (ttm)
- 14.3×
- Fwd P/E
- 16.6×
- P/S (ttm)
- 3.1×
- P/B (mrq)
- 2.1×
- P/FCF (ttm)
- 14.9×
- EV/EBITDA (fy)
- 14.8×
- EV/Sales (ttm)
- 3.7×
- FCF yield (ttm)
- 6.70%
- Buyback yield (realized, 1y)
- 1.45%
- Shareholder yield (realized, 1y)
- 3.31%
- Buyback yield (cash, ttm)
- 0.44%
- Shareholder yield (cash, ttm)
- 2.21%
Vs own 10Y history
- P/E
- 26th
- P/OI
- 23rd
- P/S
- 77th
- P/B
- 64th
- P/FCF
- 15th
Bar = where today’s multiple sits in HLN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+0.30%
5D
+7.73%
1M
+9.59%
3M
+1.29%
YTD
+0.59%
1Y
+8.08%
5Y
—
Recent filings#
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →Financial statements
Open full HLN financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
